1. Home
  2. FLNT vs PMVP Comparison

FLNT vs PMVP Comparison

Compare FLNT & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluent Inc.

FLNT

Fluent Inc.

HOLD

Current Price

$2.93

Market Cap

90.9M

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.15

Market Cap

76.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNT
PMVP
Founded
2010
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.9M
76.8M
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
FLNT
PMVP
Price
$2.93
$1.15
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
218.9K
250.6K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
41.67
N/A
EPS
N/A
N/A
Revenue
$208,764,000.00
N/A
Revenue This Year
$5.89
N/A
Revenue Next Year
$12.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$0.96
52 Week High
$4.15
$1.88

Technical Indicators

Market Signals
Indicator
FLNT
PMVP
Relative Strength Index (RSI) 63.28 43.29
Support Level $2.95 $1.12
Resistance Level $3.60 $1.26
Average True Range (ATR) 0.31 0.06
MACD 0.11 0.00
Stochastic Oscillator 69.72 38.00

Price Performance

Historical Comparison
FLNT
PMVP

About FLNT Fluent Inc.

Fluent Inc is a commerce media solutions provider that connects brands with engaged consumers by leveraging diverse advertising inventory, robust first-party data, and proprietary machine learning. The company mainly delivers customer acquisition services through scalable digital marketing campaigns, linking advertisers with targeted audiences. It reaches consumers through its Commerce Media Solutions, which integrate targeted advertising into e-commerce and digital media transaction flows on partner websites and mobile applications, as well as through its owned and operated digital media properties. The company operates in the United States, which generates the majority of its revenue, along with international markets.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: